Covid-19 vaccines: latest on research
Vaccines could dramatically slow the spread of coronavirus (Covid-19), and researchers are collaborating like never before to develop them in record time. Without vaccines, distributed equitably all over the world, we could face recurring waves of the epidemic.
There are currently more than 320 possible Covid-19 vaccines in development, with some now approved for use. This is a historic moment and the result of a global, collaborative research effort.
Some of the cutting-edge methods used during this outbreak could revolutionise vaccine development in future.
Without vaccines, distributed equitably all over the world, we could face recurring waves of Covid-19.
More explainers
Read more news and opinions on Covid-19 and visit our YouTube channel.
We’re supporting global vaccine research and development efforts through CEPI, the Coalition for Epidemic Preparedness Innovations.
CEPI is currently funding the development of nine Covid-19 vaccines. Several are in phase III clinical trials.
We’re also calling for governments, businesses and philanthropy to support the Covid-19 vaccine process, from research and development to manufacturing and delivery – to make sure that there are enough vaccines available for everyone who needs one. The funds raised so far are a positive first step, but greater investment is needed.
There will be huge demand from countries around the world, and any new Covid-19 vaccines must first be made available to those who need them most, not just those who can afford to buy them.
Pooling money and expertise will be the fastest, most effective way to end the pandemic. Organisations like Gavi, UNICEF and the World Health Organization, and global collaborations like the ACT Accelerator and the COVID-19 Vaccine Global Access Facility (COVAX), will play a vital role in ensuring access to a Covid-19 vaccine alongside the life-saving vaccines we already have.
To contact someone in the team, email vaccines@wellcome.org.
See who’s who in the vaccines team.
